City page
Photo: Flocci Nivis · CC BY 4.0Berlin biotech and pharma directory
Berlin is one of Europe's largest urban biotech ecosystems — anchored by Bayer's Berlin pharmaceutical R&D HQ (the city is home to Bayer's legacy Schering operations), Berlin-Chemie (specialty pharma), the Max Delbrück Center for Molecular Medicine (MDC), the Berlin Institute of Health (BIH), and Charité — Universitätsmedizin Berlin (Europe's largest university hospital). The startup ecosystem in Berlin Adlershof and Buch concentrates emerging biotech, with strong digital health overlap.
Where does this city read strongest?
Therapeutics (3), Research (2), and Cluster (1). Most visible records: JPT Peptide Technologies, 3B Pharmaceuticals, and TissUse.
Which standards and public evidence are already visible?
GMP (2), GLP (1), and ISO-13485 (1). Latest review: 22 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Berlin.
By category
Berlin by category
Jump into a category page filtered to this country only.
Full list
Berlin biotech and pharma directory
9 city records currently match the active filter.
Current review cycle
JPT Peptide Technologies
BerlinGermanyTools
Berlin peptide-technology company producing research, assay, and clinical-grade peptide products for immunology, oncology, and biomarker workflows.
- Lead
- Aurelien ClaeyssenManaging Director
- Scale
- Global peptide products platform
Current review cycle
3B Pharmaceuticals
BerlinGermanyTherapeutics
Berlin radiopharmaceutical company developing peptide-targeted cancer therapeutics and companion diagnostics from a German translational-oncology base.
- Lead
- Ulrich HaagmannChief Executive Officer
- Scale
- Development-stage radiopharma platform
Current review cycle
TissUse
BerlinGermanyResearch
Berlin organ-on-chip company developing multi-organ microphysiological systems for drug development, toxicology, and advanced human tissue models.
- Lead
- Uwe MarxChief Executive Officer
- Scale
- Research-platform operations
Current review cycle
T-Knife
BerlinGermanyTherapeutics
Berlin T-cell therapy company building TCR-engineered cell therapies for solid tumors from a German oncology platform.
- Lead
- Gabriele EisnerChief Executive Officer
- Scale
- Clinical-stage cell-therapy platform
Current review cycle
ProBioGen
BerlinGermanyCDMO
Berlin CDMO and biologics technology company providing cell-line development, process development, and GMP manufacturing services for complex biopharmaceuticals.
- Lead
- Volker SandigChief Executive Officer and Chief Scientific Officer
- Scale
- Commercial and clinical biopharma platform
Current review cycle
Campus Berlin-Buch
BerlinGermanyCluster
Berlin-Buch science and biotech campus integrating research institutes, translational platforms, spinouts, and grow-out infrastructure for biomedical companies.
- Lead
- Dr. Christina Quensel / Dr. Ulrich SchellerManaging Directors
- Scale
- Berlin-Buch biotech campus operations
Current review cycle
Eckert & Ziegler
BerlinGermanyManufacturing
Berlin radiopharma and isotope-products anchor spanning medical isotopes, radiation components, and nuclear-medicine supply.
- Lead
- Dr. Harald HasselmannChief Executive Officer
- Scale
- International isotope and radiopharma platform
Current review cycle
Max Delbruck Center Berlin-Buch
BerlinGermanyResearch
Berlin-Buch biomedical research centre combining disease-biology programmes, technology platforms, and translational partnerships across the German capital region.
- Lead
- Prof. Dr. Maike SanderChair of the Board and Scientific Director
- Scale
- Large biomedical research centre
Current review cycle
Apogenix AG
BerlinGermanyTherapeutics
Heidelberg immunotherapy developer focused on TNFSF pathway biology and clinical-stage oncology programs built from its asunercept platform.
- Lead
- Dr. Thomas HoegerChief Executive Officer
- Scale
- Clinical Research
FAQ
Frequently asked questions
- What biotech companies are headquartered in Berlin?
- Bayer's pharmaceutical R&D and global headquarters for several therapeutic areas operate from Berlin (legacy Schering AG operations). Berlin-Chemie (now part of Menarini Group) is a major specialty pharma. Mid-cap and emerging biotech includes a growing cohort anchored by MDC, Charité-BIH, and the Berlin Adlershof / Buch science parks.
- What research institutions anchor Berlin biotech?
- The Max Delbrück Center for Molecular Medicine (MDC, part of the Helmholtz Association) — focused on cardiovascular, oncology, and systems biology. The Berlin Institute of Health (BIH) — translational medicine. Charité — Universitätsmedizin Berlin — Europe's largest university hospital. Together they form one of Europe's deepest biomedical research bases.
- How does Berlin compare to Heidelberg or Munich for biotech?
- Berlin = urban scale, big pharma R&D (Bayer), strong academic medicine (Charité), startup density. Heidelberg = compact research-intensive cluster (DKFZ, EMBL). Munich = strong life sciences cluster (MorphoSys, Roche Diagnostics nearby in Penzberg). Each has a distinct mix; Berlin is the broadest urban entry point.
Related briefs
Briefs that mention Berlin
Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus
Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.
Open briefGerman Biotech & Pharma Landscape 2026: Heidelberg, Berlin, Mainz
A practical map of the German biotech and pharma landscape in 2026 — 57 operators across Heidelberg, Berlin, Mainz, Hamburg, Munich, and smaller sites, organised by what they actually do and how the pieces connect.
Open briefCell & Gene Therapy Europe 2026: CAR-T, Stem Cell, ATMP, Regenerative
A practical map of the European cell and gene therapy landscape in 2026 — CAR-T and TCR-T therapeutics, stem-cell and regenerative ATMPs, tissue engineering, plus the viral-vector CDMO and tools supply chain — across 26 operators in the directory.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.